human ttp (Santa Cruz Biotechnology)
Structured Review

Human Ttp, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 47 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ttp/TTP+siRNA/pm36430156-313-5-19
Average 93 stars, based on 47 article reviews
Images
1) Product Images from "FOXO1 Is a Key Mediator of Glucocorticoid-Induced Expression of Tristetraprolin in MDA-MB-231 Breast Cancer Cells."
Article Title: FOXO1 Is a Key Mediator of Glucocorticoid-Induced Expression of Tristetraprolin in MDA-MB-231 Breast Cancer Cells.
Journal: International journal of molecular sciences
doi: 10.3390/ijms232213673
Figure Legend Snippet: Figure 1. Dose-dependent induction of TTP in MDA-MB-231 cells by three compounds selected from the fourth screening of the natural compound library. (A) Dose-dependent changes in luciferase activity. MDA-MB-231 cells were transfected with pGL3/TTPp-1343 luciferase reporter vector containing the human TTP promoter, followed by stimulation with different concentrations of three selected compounds solubilized in DMSO for 48 h. The same volume of DMSO was added to the cells as controls. For each compound, the fold change in luciferase activity of stimulated cells was calculated relative to that of the DMSO control. The graphs are mean ± SD of three independent experiments (Two-way ANOVA). Black bars, control; red bars, 01-E10; green bars, 01-G05; violet bars, 05-A06. (B–D) Dose-dependent changes in endogenous TTP level. MDA-MB-231 cells were stimulated with different concentrations of compounds (B) 01-E10, (C) 01-G05, and (D) 05-A06 for 48 h. The expression level of TTP mRNA was analyzed by qRT-PCR. For each compound, the fold change in expression level was calculated relative to that of the DMSO control. The graphs are mean ± SD of three independent experiments (one-way ANOVA, * p < 0.01). (E) Structure of compound 05-A06, an enantiomer of BTM-21-P and DXM-21-P.
Techniques Used: Drug discovery, Luciferase, Activity Assay, Transfection, Plasmid Preparation, Control, Expressing, Quantitative RT-PCR
Figure Legend Snippet: Figure 6. DXM-induced TTP mediates the anti-viability function of DXM in MDA-MB-231 cells. (A–C) DXM treatment decreases expression of ARE-containing genes in MDA-MB-231 cells. MDA- MB-231 cells were stimulated with 500 nM DXM, and the expression of ARE-containing genes such as (A) Myc, (B) VEGF, and (C) COX2 was analyzed by qRT-PCR. Fold change in expression level was calculated relative to that of the DMSO control. The graphs are mean ± SD of three independent experiments (Student’s t test, * p < 0.05). (D) TTP mediates the anti-viability function of DXM in MDA-MB-231 cells. MDA-MB-231 cells were transfected with TTP-specific siRNA (siTTP) or control scrambled siRNA (scRNA) and stimulated with 500 nM DXM. Viability of MDA-MB-231 cells was assessed using MTS assays. Graphs show relative cell viability. Data are mean ± SD of three independent experiments (one-way ANOVA, ** p < 0.01).
Techniques Used: Expressing, Quantitative RT-PCR, Control, Transfection
Related Articles
Control:Article Title: TTP enhances the sensitivity of KRAS G12C -mutated lung cancer cells to KRAS G12C inhibitors by downregulating SLC7A11 and promoting ferroptosis. Article Snippet: Cells were transfected with plasmid constructs using TurboFectTM in vitro transfection reagent (Thermo Scientific, R0531). .. Small interfering RNAs (siRNAs) against Article Title: Tristetraprolin regulates phagocytosis through interaction with CD47 in head and neck cancer Article Snippet: .. HN31 cells was transfected with 45 nM of Article Title: Predictors of Nodal Disease in Rectal Cancer Patients with Complete Mucosal Response to Neoadjuvant Therapy. Article Snippet: The mRNA destabilizing factor tristetraprolin (TTP) functions as a tumor suppressor by down-regulating cancer-associated genes.. TTP expression is significantly reduced in various cancers, which contributes to cancer processes.. Enforced expression of TTP impairs tumorigenesis and abolishes maintenance of the malignant state, emphasizing the need to identify a TTP inducer in cancer cells. Article Title: FOXO1 Is a Key Mediator of Glucocorticoid-Induced Expression of Tristetraprolin in MDA-MB-231 Breast Cancer Cells Article Snippet: The pGR-wt, pGR dim , and pFOXO1-Flag plasmids were purchased from Addgene (Watertown, MA, USA). .. Small interfering RNAs (siRNAs) against human TTP (TTP-siRNA, sc-36761) and Transfection:Article Title: Tristetraprolin regulates phagocytosis through interaction with CD47 in head and neck cancer Article Snippet: .. HN31 cells was transfected with 45 nM of Synthesized:Article Title: Degradation of MK2 with natural compound andrographolide: A new modality for anti-inflammatory therapy. Article Snippet: MK2 ADP-Glo kinase assay kit was from Promega (Madison, WI). .. All primer pairs were synthesized by Integrated DNA Technologies (Coralville, IA). siRNAs for MK2 (m) (CAT# sc-35856), |
